136 related articles for article (PubMed ID: 7970549)
1. Visual prognosis in patients with Behçet's disease receiving colchicine, systemic corticosteroid or cyclosporin.
Hayasaka S; Kawamoto K; Noda S; Kodama T
Ophthalmologica; 1994; 208(4):210-3. PubMed ID: 7970549
[TBL] [Abstract][Full Text] [Related]
2. Infliximab monotherapy versus infliximab and colchicine combination therapy in patients with Behçet's disease.
Takeuchi M; Asukata Y; Kawagoe T; Ito N; Nishide T; Mizuki N
Ocul Immunol Inflamm; 2012 Jun; 20(3):193-7. PubMed ID: 22486264
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of corticosteroids and cyclosporin in the treatment of retinal vasculitis in patients with Behçet's disease.
Ermakova NA
Adv Exp Med Biol; 2003; 528():563-5. PubMed ID: 12918765
[No Abstract] [Full Text] [Related]
4. Could nicotine be beneficial for Behçet's disease?
Kaklamani VG; Markomichelakis N; Kaklamanis PG
Clin Rheumatol; 2002 Aug; 21(4):341-2. PubMed ID: 12296287
[No Abstract] [Full Text] [Related]
5. A case of Behçet's disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab.
Hirano T; Ohguro N; Hohki S; Hagihara K; Shima Y; Narazaki M; Ogata A; Yoshizaki K; Kumanogoh A; Kishimoto T; Tanaka T
Mod Rheumatol; 2012 Apr; 22(2):298-302. PubMed ID: 21748365
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of cyclophosphamide and colchicine treatment in Behçet's disease.
Kazokoglu H; Saatçi O; Cuhadaroglu H; Eldem B
Ann Ophthalmol; 1991 Apr; 23(4):148-51. PubMed ID: 2064258
[TBL] [Abstract][Full Text] [Related]
7. Low dose cyclosporin-A therapy in Behçet's disease.
Sajjadi H; Soheilian M; Ahmadieh H; Hassanein K; Parvin M; Azarmina M; Ehyaee V; Amiransari B
J Ocul Pharmacol; 1994; 10(3):553-60. PubMed ID: 7836864
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporin-A therapy in severe uveitis of Behçet's disease.
Süllü Y; Oge I; Erkan D; Aritürk N; Mohajeri F
Acta Ophthalmol Scand; 1998 Feb; 76(1):96-9. PubMed ID: 9541443
[TBL] [Abstract][Full Text] [Related]
9. Epidemiological features and visual prognosis of Behçet's disease.
Ando K; Fujino Y; Hijikata K; Izawa Y; Masuda K
Jpn J Ophthalmol; 1999; 43(4):312-7. PubMed ID: 10482479
[TBL] [Abstract][Full Text] [Related]
10. A case of tuberculous meningoencephalitis in a patient with Behçet's disease.
Iliopoulos A; Kedikoglou S; Laxanis S; Kourouklis S; Katsaros E
Clin Rheumatol; 2006 Feb; 25(1):121-2. PubMed ID: 15902513
[No Abstract] [Full Text] [Related]
11. Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease.
Masuda K; Nakajima A; Urayama A; Nakae K; Kogure M; Inaba G
Lancet; 1989 May; 1(8647):1093-6. PubMed ID: 2566048
[TBL] [Abstract][Full Text] [Related]
12. Interferon alfa-2b, colchicine, and benzathine penicillin versus colchicine and benzathine penicillin in Behçet's disease: a randomised trial.
Demiroglu H; Ozcebe OI; Barista I; Dündar S; Eldem B
Lancet; 2000 Feb; 355(9204):605-9. PubMed ID: 10696980
[TBL] [Abstract][Full Text] [Related]
13. Use of colchicine in Behçet's syndrome.
Sander HM; Randle HW
Cutis; 1986 May; 37(5):344-8. PubMed ID: 3519102
[TBL] [Abstract][Full Text] [Related]
14. Colchicine in Behçet's disease with major vessel thrombosis.
Celik G; Kalaycioğlu O; Durmaz G
Rheumatol Int; 1996; 16(1):43-4. PubMed ID: 8783422
[No Abstract] [Full Text] [Related]
15. Combined cyclosporine and corticosteroid therapy for sight-threatening uveitis in Behçet's disease.
Whitcup SM; Salvo EC; Nussenblatt RB
Am J Ophthalmol; 1994 Jul; 118(1):39-45. PubMed ID: 8023874
[TBL] [Abstract][Full Text] [Related]
16. [A case of Behçet's disease associated with neuromyopathy induced by combination therapy with colchicine and cyclosporin].
Fujii Y; Arimura Y; Takahashi N; Toki T; Marumo T; Yoshihara K; Nakabayashi K; Yamada A
Ryumachi; 2003 Feb; 43(1):44-50. PubMed ID: 12692989
[TBL] [Abstract][Full Text] [Related]
17. Optic nerve involvement in neuro-Behcet's disease.
Nakamura T; Takahashi K; Kishi S
Jpn J Ophthalmol; 2002; 46(1):100-2. PubMed ID: 11853723
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporine in Behçet's disease resistant to conventional therapy.
Caspers-Velu LE; Decaux G; Libert J
Ann Ophthalmol; 1989 Mar; 21(3):111-6, 118. PubMed ID: 2735696
[TBL] [Abstract][Full Text] [Related]
19. Late-onset Behçet's disease does not correlate with indolent clinical course: report of seven Taiwanese patients.
Tsai J; Chen GS; Lu YW; Wu CS; Lan CC
J Eur Acad Dermatol Venereol; 2008 May; 22(5):596-600. PubMed ID: 18266686
[TBL] [Abstract][Full Text] [Related]
20. Prognosis in Behcet's disease.
Pivetti Pezzi P; Gasparri V; De Liso P; Catarinelli G
Ann Ophthalmol; 1985 Jan; 17(1):20-5. PubMed ID: 3977213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
